
Hims & Hers Stock Is Soaring Again. But Should You Buy the Stock?
Many companies have failed to disrupt the complicated U.S. healthcare market. Hims & Hers (NYSE: HIMS) may finally be succeeding in cracking the code. The online telehealth platform focuses on circumventing the insurance market; its business of selling affordable medications directly to individuals is growing like a weed, and expects to generate $6.5 billion in revenue by 2030.
It has had a tumultuous start to 2025, as Hims & Hers waged a battle to sell new weight loss medications on its online marketplace. Now, with momentum back on its side, the stock is up 118% year to date and 446% in the last five years. Let's take a deeper look at this company, and see whether you might want to buy Hims & Hers stock for your portfolio now.
Disrupting the healthcare market
Hims & Hers' model is simple. It has two separate web platforms -- Hims for men and Hers for women -- that sell medications and deliver to customers' front doors. It began with sexual health, but has moved into dermatology, hair loss, mental health, and now weight loss medications.
A key to its success has been avoiding the insurance market with products that don't break the bank. Customers loathe dealing with health insurers in the United States, and sometimes would rather not use insurance at all. Plus, some of these products aren't covered by insurance.
This strategy has helped the company close in on over $2 billion in projected revenue in 2025. To keep up this impressive growth, Hims & Hers wants to offer weight loss medications, which have been a blockbuster set of drugs for the pharmaceutical market. For a while the popularity of these drugs, such as Novo Nordisk 's Wegovy, left them in short supply; that allowed third parties such as Hims & Hers to produce them as a compounding pharmacy and sell them at much cheaper prices. This ended up generating $200 million of Hims & Hers' $1.4 billion in 2024 revenue.
But with the shortage of Wegovy over and the compounding pharmacy exception ended, the company's weight-loss business was at a major turning point. Luckily, at the end of April Hims & Hers announced a partnership with Novo Nordisk that seems to resolve this issue: It gives Hims & Hers the ability to sell Wegovy directly on its platform. Hims & Hers is not an exclusive supplier of the drug -- or any drugs on its marketplaces, to be fair -- but it hopes to use its subscription business model, marketing expertise, and simplified user proposition to drive sales for Novo Nordisk in the huge obesity-care market.
Going abroad and personalization
Besides weight loss drugs, Hims & Hers has more ambitions to reach its goal of $6.5 billion in revenue by 2030. Just recently, the company announced its intent to acquire European competitor Zava so it could expand its telehealth service to Europe. The acquisition will add a platform with 1.3 million active customers in the U.K., Germany, France, and Ireland. It makes sense that Hims & Hers can supercharge growth for the platform with its plethora of medications offered to customers, keen marketing skills, and subscription-based selling model.
Over the long run, Hims & Hers aims to make healthcare for its customers more personalized. This includes unique drug combinations, its own outsourcing facility, and at-home testing capabilities. Details remain sparse, but the vision is clear: disrupting more and more of the trillions of dollars spent on healthcare by building a business that people actually enjoy interacting with. This is why 2.4 million active customers use Hims & Hers today.
HIMS Gross Profit Margin data by YCharts.
Should you buy Hims & Hers stock?
A revenue goal of $6.5 billion seems well within reach by 2030. Hims & Hers is only at 2.4 million active customers, and there are tens of millions of people in the United States alone who could start using or switch to one of its telehealth platforms. Add on the Zava acquisition in Europe, and the runway for growth gets even larger.
The company has an impressive gross profit margin of 77%, which should lead to high levels of profitability at scale. On $6.5 billion in future revenue, it could very well post a net profit margin of over 20%, and achieve $1.5 billion in bottom-line profits and free cash flow. A 20% profit margin is easily achievable because of its high gross margins and the fact it currently spends 40% of revenue on marketing today, a figure that has come down over time and should come down even more as Hims & Hers keeps scaling.
However, Hims & Hers has played fast and loose with laws and regulations in the past. It sold weight loss drugs when the legality of doing so was unclear, and although that dispute seems to have been resolved, management could easily start playing with fire again and burn its reputation as a trusted provider of medications.
Otherwise, this looks like a fantastic growth stock that just doubled its addressable market with the Zava acquisition. Today, Hims & Hers has a market cap of $12.3 billion. You might think it's overvalued because of the stock's recent run-up in price, but the numbers show that patient investors could be rewarded by holding for the long term.
A $12.3 billion market cap is only around 8 times my 2030 earnings estimate of $1.5 billion, which would be a dirt cheap price-to-earnings (P/E) ratio for a fast-growing company compared to the current market cap. Most likely, the stock will be valued at a higher multiple than 8, meaning that the stock will be higher in five years. It doesn't come without risks, but if you're a growth investor, you might love Hims & Hers stock for its long-term potential.
Should you invest $1,000 in Hims & Hers Health right now?
Before you buy stock in Hims & Hers Health, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Hims & Hers Health wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $669,517!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $868,615!*
Now, it's worth noting Stock Advisor 's total average return is792% — a market-crushing outperformance compared to173%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor.
See the 10 stocks »
*Stock Advisor returns as of June 2, 2025
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Globe and Mail
28 minutes ago
- Globe and Mail
Digital Silk Launches Purpose-Driven Web Design for Project Fire Buddies, Fueling Engagement and Community Support
Miami, Florida--(Newsfile Corp. - June 12, 2025) - Digital Silk, an award-winning agency focused on creating brand strategies, custom websites and digital marketing campaigns, has launched a new purpose-led digital platform for Project Fire Buddies. This non-profit organization partners with fire departments across the U.S. to bring joy to children battling critical illnesses. The website revamp is part of Digital Silk's mission to support cause-based organizations through strategic web design that fosters engagement and community involvement. Bringing Joy Online: Project Fire Buddies' Mission Comes to Life Through Engaging New Website To view an enhanced version of this graphic, please visit: From February 6 to May 6, 2025, the new website achieved impactful early results: +16.2% increase in average engagement time per user, showing visitors are connecting more deeply with the content +37.4% rise in engagement events such as clicks and scrolls across pages +3.8% increase in organic and direct traffic, despite a decline in total users Over 13.3K pageviews driven by the homepage and the "Chapters" section, indicating interest in the organization's reach and mission The redesign aimed to tell the Project Fire Buddies story through an intuitive, emotionally resonant interface with clear calls to action for support and participation. The full case study is available at: Human-Centered Website Development Enhancing Visibility and Support Digital Silk built the platform with accessibility, ease of navigation and emotional storytelling at its core. The homepage, mission and chapter pages now deliver a more immersive journey, helping to inform, inspire and mobilize visitors. "Project Fire Buddies is more than a website – it's a movement," said Gabriella Garcia, Senior Project Manager at Digital Silk. "Our team worked closely with their leadership to create a site experience that would amplify their impact and encourage more people to get involved." Key Results from the Digital Transformation The platform's performance metrics over its first 90 days show promising signs of long-term success and support for the non-profit's mission: Average session duration rose, indicating content relevance and design effectiveness Users interacted more with key calls to action, increasing potential for donations and volunteer involvement Direct and organic traffic grew, a strong indicator of improved visibility and search presence About Project Fire Buddies Project Fire Buddies was created by local firefighters to build relationships and boost the morale of critically ill children. By expanding across multiple fire departments, Project Fire Buddies developed a national presence — now supported by a centralized and engaging online platform built by Digital Silk. About Digital Silk Digital Silk is an award-winning Miami web design agency focused on growing brands online. With a team of seasoned experts, Digital Silk delivers industry-leading digital experiences through strategic branding and cutting-edge web design to support engagement and visibility through custom marketing strategies.


Globe and Mail
28 minutes ago
- Globe and Mail
Rocket Lab Successfully Launches Its 66th Electron Rocket
Rocket Lab USA Inc. RKLB recently completed its 66th successful Electron rocket launch. The latest launch mission encompassed the deployment of the QPS-SAR-11 satellite into the Earth's orbit. This mission is part of the contract that Rocket Lab secured in February 2025, from Japan-based Earth imaging company iQPS, marking one of its largest Electron launch agreements to date. This deal involves eight dedicated Electron launches, with six missions scheduled for 2025, out of which four are already completed, and two in 2026. Such successful missions reflect RKLB's proven expertise in launch services and further strengthen its footprint in the space industry. What's Favoring RKLB Stock? In the modern era of space exploration, factors like rapid technological advancements, the growing demand for satellite deployment, increasing commercial space activities and rising investments in space infrastructure are fueling the growth of the space launch services market. This must have prompted the Grand View Research firm to estimate that the global space launch services market will witness a compound annual growth rate of 15.6% during the 2024-2030 time period. Such robust market growth prospects are expected to benefit companies like Rocket Lab. With its advanced Electron rocket and expanding capabilities in small satellite launches, the company is well-positioned to leverage the booming demand for frequent and cost-effective launches. It is also making strides in reusable rocket technology, which significantly reduces costs and improves launch efficiency. To capture further market shares, Rocket Lab is currently developing the Neutron rocket, designed for larger payloads and constellation deployments. This new product should further bolster RKLB's position in the market and fetch solid revenues. Opportunities for Other Space Stocks Other companies that are expected to enjoy the perks of the expanding global space launch services market have been discussed below. Northrop Grumman Corporation NOC: It is one of the key players in the space industry, providing launch vehicles and propulsion systems through its space systems division. The company's innovations in rocket technology and satellite deployment make it a significant beneficiary of the growing demand for space launch services. Northrop has a long-term (three to five years) earnings growth rate of 3.3%. The Zacks Consensus Estimate for NOC's 2025 sales indicates year-over-year growth of 2.8%. The Boeing Company BA and Lockheed Martin Corporation 's LMT joint venture, United Launch Alliance ('ULA'), has been the United States' premier launch services provider since its establishment in 2006. The JV has successfully launched more than 150 Atlas and Delta rockets since 2006. Boeing has a long-term earnings growth rate of 18.1%, while that for Lockheed is pegged at 10.5%. The Zacks Consensus Estimates for BA and LMT's 2025 sales indicates year-over-year growth of 25.6 and 4.7%, respectively. RKLB Stock's Price Movement Shares of RKLB have gained 501.3% in the past year compared with the industry 's 42.2% growth. RKLB's Zacks Rank RKLB currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. 5 Stocks Set to Double Each was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%. Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor. Today, See These 5 Potential Home Runs >> Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report The Boeing Company (BA): Free Stock Analysis Report Lockheed Martin Corporation (LMT): Free Stock Analysis Report Northrop Grumman Corporation (NOC): Free Stock Analysis Report Rocket Lab Corporation (RKLB): Free Stock Analysis Report


Globe and Mail
28 minutes ago
- Globe and Mail
Is AI-driven Power Demand Aiding GE Vernova's Gas Power Business?
The growth of artificial intelligence (AI) and cloud computing has been significantly increasing electricity consumption of late, especially in hyperscale data centers worldwide. Surging electricity consumption is driving the need for a reliable and constant power supply, resulting in growing demand for power-generation equipment like those manufactured by GE Vernova Inc. GEV. To this end, GEV's gas power business is witnessing notable traction in recent times, particularly in terms of growing gas turbine orders, which play a critical role in the energy transition industry. The company signed 7 gigawatts (GW) of gas turbine orders, raising its Gas Power equipment backlog to a solid 29 GW, with its gas turbine order registering an 11.8% year-over-year growth in first-quarter 2025. As the company continues to collaborate with major corporations through the supply of its advanced turbine technology and other power equipment, in a bid to meet the massive energy needs of the expanding digital economy, its Gas Power unit will continue to grow. Notably, this unit recorded year-over-year revenue growth of 17.7% in the first quarter of 2025. In April 2025, GE Vernova signed an agreement with utility provider, Duke Energy DUK, to provide up to 11 of its 7HA gas turbines and other associated equipment to support the latter's electricity generation facilities. This order came in addition to the eight turbines of GEV that Duke Energy had previously acquired. In the same month, GEV entered into a partnership with energy giant Chevron Corp. CVX. Per the terms of the agreement, GEV will supply seven 7HA gas turbines that will help Chevron deliver 4 GW of power by 2027. CVX stands early in the queue to receive some of the largest gas turbines that GE Vernova manufactures, with the deliveries scheduled to start in 2026. Looking ahead, with global electricity demand projected to double by 2050, as predicted by the International Energy Agency in 2024, GE Vernova's Gas Power stands to benefit from the combined impact of tech-driven electricity consumption trends and strategic partnerships like those mentioned above. The Zacks Rundown for GEV Shares of GE Vernova surged a solid 46.9% year to date, outperforming the industry 's 15.5% gain. From a valuation standpoint, GEV is currently trading at a trailing 12-month price-to-earnings (P/E) multiple of 52.69X, a roughly 148.5% premium when stacked up with the industry average of 21.20X. The Zacks Consensus Estimate for GEV's 2025 and 2026 sales suggests a year-over-year improvement of 6.4% and 10%, respectively. The bottom-line estimate for 2025 and 2026 has moved north over the past 60 days. GEV currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. 5 Stocks Set to Double Each was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%. Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor. Today, See These 5 Potential Home Runs >> Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Chevron Corporation (CVX): Free Stock Analysis Report Duke Energy Corporation (DUK): Free Stock Analysis Report GE Vernova Inc. (GEV): Free Stock Analysis Report This article originally published on Zacks Investment Research (